Thursday, November 14, 2024
HomeTagsCoStAR

CoStAR

Instil Bio Announces Oral Presentation of ITIL-306 Preclinical Data at British Society for Gene and Cell Therapy Annual Conference

Instil Bio, Inc., a clinical-stage biopharmaceutical company focused on developing tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer, today...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics